BFRG Stock - Bullfrog AI Holdings, Inc. Common Stock
Unlock GoAI Insights for BFRG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $65,000 | $10,000 | N/A | N/A |
| Gross Profit | N/A | $59,800 | $9,200 | N/A | N/A |
| Gross Margin | N/A | 92.0% | 92.0% | N/A | N/A |
| Operating Income | $-7,236,383 | $-5,367,524 | $-2,455,801 | $-555,362 | $-347,193 |
| Net Income | $-6,993,647 | $-5,355,869 | $-2,802,487 | $-585,840 | $-341,690 |
| Net Margin | N/A | -8239.8% | -28024.9% | N/A | N/A |
| EPS | $-0.85 | $-0.89 | $-0.46 | $-0.10 | $-0.06 |
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Visit WebsiteEarnings History & Surprises
BFRGEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-0.15 | — | — |
Q3 2025 | Aug 13, 2025 | — | $-0.15 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.21 | — | — |
Q1 2025 | Mar 14, 2025 | — | $-0.18 | — | — |
Q4 2024 | Nov 8, 2024 | — | $-0.22 | — | — |
Q3 2024 | Aug 7, 2024 | — | $-0.20 | — | — |
Q2 2024 | May 10, 2024 | — | $-0.26 | — | — |
Q1 2024 | Mar 29, 2024 | — | $-0.17 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.21 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.24 | — | — |
Q2 2023 | May 24, 2023 | — | $-0.27 | — | — |
Q2 2023 | Apr 25, 2023 | — | $-0.11 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.14 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.15 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.10 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Latest News
'There will be no federal bailout for AI. The U.S. has at least 5 major frontier model companies.
➖ NeutralBullfrog AI Holdings Files Prospectus Relates To Resale, From Time To Time, Of Up To 5M Shares By Lincoln Park Capital Fund
➖ NeutralBullfrog AI Holdings Expands Its Internal Sales Team To Support The Accelerated Commercialization Of Its Clinical Trial Optimization Solutions, Including Recently Launched bfPREP Module
📈 PositiveBullFrog AI Enters $10M Common Stock Purchase Agreement With Lincoln Park Capital
📈 PositiveBullFrog AI Holdings Provides Update On Collab With Eleison Pharmaceuticals; BullFrog AI And Eleison Prepare Joint Scientific Submission To Upcoming Oncology Conference; Exploring Further Collaboration Through Second Contract For Additional Collaboration Work
📈 PositiveFrequently Asked Questions about BFRG
What is BFRG's current stock price?
What is the analyst price target for BFRG?
What sector is Bullfrog AI Holdings, Inc. Common Stock in?
What is BFRG's market cap?
Does BFRG pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BFRG for comparison